Reports suggested that NLK overexpression can inhibit the occurrence of EMT and subsequently inhibit the proliferation and migration of non-small cell lung cancer (NSCLC) by affecting E-cadherin protein expression [34, 35]. The gene discussed is NLK; the disease is non-small cell lung carcinoma.